SE7612964L - Tienamycinderivat - Google Patents
TienamycinderivatInfo
- Publication number
- SE7612964L SE7612964L SE7612964A SE7612964A SE7612964L SE 7612964 L SE7612964 L SE 7612964L SE 7612964 A SE7612964 A SE 7612964A SE 7612964 A SE7612964 A SE 7612964A SE 7612964 L SE7612964 L SE 7612964L
- Authority
- SE
- Sweden
- Prior art keywords
- derivatives
- tienamycin
- substituents
- compounds
- thienamycin
- Prior art date
Links
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N imipenem Chemical class C1C(SCC\N=C\N)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical class C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 229940100198 alkylating agent Drugs 0.000 abstract 1
- 239000002168 alkylating agent Substances 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
- C07D477/20—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63429775A | 1975-11-21 | 1975-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE7612964L true SE7612964L (sv) | 1977-05-22 |
Family
ID=24543224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7612964A SE7612964L (sv) | 1975-11-21 | 1976-11-19 | Tienamycinderivat |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS5277085A (enExample) |
| CH (1) | CH628051A5 (enExample) |
| DE (1) | DE2652676A1 (enExample) |
| DK (1) | DK523676A (enExample) |
| FR (1) | FR2332014A1 (enExample) |
| GB (1) | GB1570988A (enExample) |
| NL (1) | NL7612937A (enExample) |
| SE (1) | SE7612964L (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU531084B2 (en) * | 1977-10-19 | 1983-08-11 | Merck & Co., Inc. | Azetidine derivatives |
| AU4061378A (en) * | 1977-10-19 | 1980-04-17 | Merck & Co., Inc. | 1-azabicyclo (3.2.0) hept-2-enes |
| DE2966187D1 (en) * | 1978-08-23 | 1983-10-27 | Beecham Group Plc | Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them |
| EP0082133A3 (en) * | 1979-04-19 | 1983-07-20 | Merck & Co. Inc. | A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids |
| US4376774A (en) * | 1979-05-29 | 1983-03-15 | Merck & Co., Inc. | Antibiotic N-heterocyclyl thienamycin |
| EP0035689B1 (en) * | 1980-02-28 | 1984-12-19 | Fujisawa Pharmaceutical Co., Ltd. | 4-substituted-2-oxoazetidine compounds, processes for their preparation, and their use for preparing antibiotics |
| JPS5798257A (en) * | 1980-12-10 | 1982-06-18 | Sankyo Co Ltd | 3,4-disubstituted azetidine-2-one compound and its preparation |
| EP0062407A1 (en) * | 1981-03-10 | 1982-10-13 | Beecham Group Plc | Therapeutic compounds containing beta-lactams |
| US4552696A (en) * | 1982-04-09 | 1985-11-12 | Bristol-Myers Company | Carbapenem antibiotics |
| US4536335A (en) * | 1982-06-18 | 1985-08-20 | Bristol-Myers Company | Carbapenem antibiotics |
| JPS5910588A (ja) * | 1982-06-18 | 1984-01-20 | ブリストル―マイヤーズ スクイブ カンパニー | カルバペネム抗生物質 |
| JP4500814B2 (ja) * | 2003-12-09 | 2010-07-14 | チョンウェ ファーマ コーポレーション | イミペネム（ｉｍｉｐｅｎｅｍ）の新規な製造方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3950357A (en) * | 1974-11-25 | 1976-04-13 | Merck & Co., Inc. | Antibiotics |
-
1976
- 1976-11-19 DE DE19762652676 patent/DE2652676A1/de not_active Withdrawn
- 1976-11-19 GB GB48238/76A patent/GB1570988A/en not_active Expired
- 1976-11-19 CH CH1462176A patent/CH628051A5/de not_active IP Right Cessation
- 1976-11-19 FR FR7634884A patent/FR2332014A1/fr active Granted
- 1976-11-19 NL NL7612937A patent/NL7612937A/xx not_active Application Discontinuation
- 1976-11-19 DK DK523676A patent/DK523676A/da unknown
- 1976-11-19 SE SE7612964A patent/SE7612964L/xx not_active Application Discontinuation
- 1976-11-22 JP JP51139653A patent/JPS5277085A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE2652676A1 (de) | 1977-06-02 |
| FR2332014A1 (fr) | 1977-06-17 |
| JPS5277085A (en) | 1977-06-29 |
| DK523676A (da) | 1977-05-22 |
| CH628051A5 (en) | 1982-02-15 |
| GB1570988A (en) | 1980-07-09 |
| FR2332014B1 (enExample) | 1978-11-10 |
| NL7612937A (nl) | 1977-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE7713134L (sv) | Heterocykliska foreningar och forfarande for framstellning derav | |
| GB1046506A (en) | Guanidine compounds and process for their manufacture | |
| AU562583B2 (en) | Substituted 1,4-dihydropyridines | |
| ES460040A1 (es) | Un procedimiento para preparar derivados de 4-hidroxifeni- lalcanolaminas. | |
| ES413639A1 (es) | Un procedimiento para la preparacion de un compuesto deri- vado de dopamina. | |
| SE7604476L (sv) | Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar | |
| CH612431A5 (en) | Process for the preparation of novel indole derivatives | |
| SE7811455L (sv) | 2-imino-imidazolidin-derivat | |
| SE7411243L (enExample) | ||
| FR2332014A1 (fr) | Derives n-alcoyles de thienamycine utiles en tant qu'antibiotiques | |
| SE7607088L (sv) | 5-fluor-uracilderivat. | |
| GB1538921A (en) | Amide derivatives of dimeric alkaloids | |
| ES466590A1 (es) | Un procedimiento para la preparacion de derivados de oxadia-zolopirimidina. | |
| GB1415471A (en) | Phenylethylamine derivatives | |
| GB1471847A (en) | Dibenzofuran derivatives | |
| ES462229A1 (es) | Un procedimiento para preparar una indol dihiindolcarboxami-da dimerica. | |
| SE7612961L (sv) | Tienamycinderivat | |
| SE8300432D0 (sv) | Reaktiva kanelsyraderivat for framstellning av biologiskt aktiva amider | |
| GB1044964A (en) | New aminoketones | |
| ES435003A1 (es) | Un proceso para la produccion de un compuesto cefem. | |
| ES444481A1 (es) | Un procedimiento para la preparacion de un derivado de ami- noalcanol. | |
| GB1108060A (en) | Indole derivatives and a process for their production | |
| AU564739B2 (en) | Acridanone derivatives | |
| SE7606592L (sv) | Nya aminobensoesyraderivat, forfarande for framstellning derav och farmaceutiska kompositioner innehallande dessa | |
| DE3469527D1 (en) | Nortropine derivative, process for its preparation and its use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 7612964-2 Format of ref document f/p: F |